Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1746 of 6351
-
Could stem cell exosomes help stroke patients recover?
Disease control CompletedThis is a multicenter, randomized, double-blinded, placebo-controlled, dose-escalation trial. The objective of this study is evaluating safety and preliminary efficacy of intravenous exosomes derived from human induced pluripotent stem cell (GD-iExo-003) in acute ischemic stroke.
Phase 1/2 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Brain imaging may expose a shared marker in PTSD and alcohol addiction
Knowledge-focused Recruiting nowThe overall objective of this study it to use Positron Emission Tomography (PET) brain imaging and a radiotracer that measures the epigenetic marker Histone Deacetylase 6 (HDAC6) to examine HDAC6 expression in people with Post-Traumatic Stress Disorder (PTSD), Alcohol Use Disorde…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Gene therapy trial aims to fix enzyme defect in fabry disease
Disease control Recruiting nowThe main goals of this clinical study are to characterize safety and PK/PD of AMT-191 i.e. if drug doses used in the study are safe and tolerable and to understand how it acts in the body of people with Fabry disease.
Phase 1/2 • Sponsor: UniQure Biopharma B.V. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New diabetes pill takes on popular drug in Head-to-Head trial
Disease control CompletedThe goal of this clinical study is to evaluate the efficacy and safety of berberine ursodeoxycholate (HTD1801) compared to dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone.
Phase 3 • Sponsor: Shenzhen HighTide Biopharmaceutical Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New drug YL205 aims to shrink advanced tumors in early trial
Disease control Recruiting nowThis study is a multicenter, open-label, phase I/II study of YL205 in China to evaluate the safety, tolerability, PK characteristics and preliminary efficacy of YL205 in the following selected patients with advanced solid tumors.
Phase 1/2 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could a shot of your own blood ease menopause symptoms?
Symptom relief CompletedVulvovaginal health is a key aspect of active and healthy aging for all women. Hormonal deprivation that occurs during menopause significantly affects the anatomy and function of urogenital tissues, leading to their atrophy. Vaginal creams and suppositories containing estrogens a…
Phase 1/2 • Sponsor: AndreiaAntunes • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New heart failure drug shows promise in Mid-Stage trial
Disease control CompletedThe main purpose of this study is to evaluate the effect of AZD5462 on cardiac function in participants with chronic heart failure (HF).
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a single therapy session ease depression in HIV care?
Symptom relief CompletedThis pilot research study will provide timely access to behavioral health services through the provision of a single-session narrative therapy intervention. The goal of this 6-month study is to test the acceptability, feasibility, and fit of the intervention in an integrated prim…
Sponsor: University of Washington • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
New therapy aims to ease long COVID symptoms
Symptom relief OngoingThis randomised controlled trial aims to investigate the efficacy of a psychological intervention for long COVID (LC) / post-COVID-19 syndrome (PCS) called Balance Acceptance and Commitment Therapy (Balance ACT). The primary objective of this trial is to investigate whether Bala…
Sponsor: King's College London • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New hope for tough leukemias: revumenib trial opens
Disease control Recruiting nowTo learn if revumenib (also known as SNDX-5613) can help to control leukemias associated with an increase in expression of HOX genes.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
A mental workout before surgery: could problem-solving coaching speed recovery in seniors?
Symptom relief CompletedThe goal of this clinical trial is to test problem solving therapy (PST) in older adults who are undergoing major surgery. The main question it aims to answer is: What is the feasibility and acceptability of delivering PST to older surgical patients with depressive symptoms or re…
Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
New pill aims to keep heart in rhythm after AFib episode
Disease control OngoingRefralon® tablets in two different doses (1 or 2 tablets per day) will be evaluated vs. placebo in patients with persistent atrial fibrillation/flutter after synus rhythm restoration in order to prevent recurrence of arrhythmia. Efficacy and safety of Refralon® tablets will be st…
Phase 2 • Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can video therapy ease PTSD in those battling opioid addiction?
Symptom relief Recruiting nowAmong individuals with opioid use disorder (OUD), posttraumatic stress disorder (PTSD) presents a significant clinical challenge. The prevalence of PTSD is substantially higher in individuals with OUD than in the general population, with nearly 90% reporting lifetime trauma expos…
Sponsor: University of Vermont • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Diet and exercise may ease long COVID symptoms in obese veterans
Disease control Recruiting nowThe research in this VA Merit will examine the effects of obesity and Post-COVID Conditions (PCC) on physical functioning, health-related quality of life, and adipose tissue inflammatory and cellular senescence profiles in older Veterans. Further, it will evaluate whether a weigh…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a nurse-led online therapy beat severe fatigue in advanced cancer?
Symptom relief Recruiting nowCancer-related fatigue is highly prevalent in patients receiving treatment for gliomas or palliative systemic treatment for cancer and is experienced as one of the most burdensome symptoms affecting patients' daily functioning and quality of life. From the KWF-sponsored TIRED tri…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a probiotic shield the liver from alcohol damage?
Disease control CompletedTo evaluate the effectiveness and safety of using probiotics to protect the liver function of long-term alcohol consumers
Sponsor: Wecare Probiotics Co., Ltd. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Could a simple surgical wash slash infection rates?
Disease control Recruiting nowThis is a multicenter randomized controlled trial of 1100 patients to evaluate the superiority of combined intraoperative wound irrigation with intraoperative peritoneal lavage with dilute aqueous povidone-iodine compared to normal saline in male and female patients between the a…
Phase 3 • Sponsor: Loma Linda University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Tape to tame Post-Surgery face swelling?
Symptom relief CompletedThe goal of this prospective clinical trial is to evaluate the additive therapeutic efficacy of Kinesio taping combined with routine post-surgical cryotherapy in reducing acute postoperative facial edema and pain in adult patients undergoing bimaxillary orthognathic surgery. The …
Sponsor: Melek Volkan Yazici • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
New hope for psoriasis patients who Didn't respond to leading therapies
Disease control CompletedThe purpose of this research study is to evaluate the effectiveness and safety of bimekizumab in individuals with moderate-to-severe psoriasis who have failed similar therapies. Bimekizumab improves psoriasis by suppressing a type of substance found in bodies called interleukins …
Phase 4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Kenya tests smartphone tool to beat child wasting crisis
Disease control Recruiting nowChild wasting is a type of malnutrition which occurs when a child becomes too thin. This medical condition increases the risk of becoming sick or dying. A child with severe wasting needs to be seen in a medical consultation to check on health status and to receive some medicine a…
Sponsor: International Food Policy Research Institute • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC